Hsinchu, Taiwan

Chin-Pen Lai

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Industrial Technology Research Institute. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chin-Pen Lai. Retrieved from https://idiyas.com/inventor/chin-pen-lai-dirkk360

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chin-Pen Lai: Innovator in Immunotherapy

Introduction

Chin-Pen Lai is a prominent inventor based in Hsinchu County, Taiwan. He has made significant contributions to the field of immunotherapy, particularly through his innovative research and patent developments. His work focuses on advancing treatments for immune-related diseases.

Latest Patents

Chin-Pen Lai holds a patent for "Anti-TIGIT antibodies and methods of use." This patent discloses antibodies and antigen-binding fragments that specifically bind to TIGIT. The disclosure further relates to methods and compositions for treating immune-related diseases, such as cancer or infections, by administering the compositions outlined in the patent. He has 1 patent to his name.

Career Highlights

Chin-Pen Lai is affiliated with the Industrial Technology Research Institute, where he conducts his research and development. His work has been instrumental in exploring new therapeutic avenues in the treatment of various diseases.

Collaborations

Chin-Pen Lai collaborates with notable colleagues, including Min-Yuan Chou and Li-Tsen Lin. Their combined expertise enhances the research efforts at the Industrial Technology Research Institute.

Conclusion

Chin-Pen Lai's contributions to immunotherapy through his innovative patents and collaborations highlight his role as a key figure in advancing medical science. His work continues to pave the way for new treatments in the field of immune-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…